NCT01811147View on ClinicalTrials.gov

Differentiating Unipolar and Bipolar Depression in Young Adults Using fMRI

PHASE4CompletedINTERVENTIONAL
Enrollment

192

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
Bipolar DisorderMajor Depression
Interventions
DRUG

Selective Serotonin Reuptake Inhibitor (SSRI)

Subjects with depression will be treated with a Selective Serotonin Reuptake Inhibitor (SSRI) or a Serotonin-norepinephrine reuptake inhibitor (SNRI) for 24 months.

Trial Locations (1)

44195

Cleveland Clinic Foundation Center for Behavioral Health, Cleveland

All Listed Sponsors
lead

The Cleveland Clinic

OTHER

NCT01811147 - Differentiating Unipolar and Bipolar Depression in Young Adults Using fMRI | Biotech Hunter | Biotech Hunter